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There is an urgent need for effective leishmanicidal drugs to replace or supplement those in current use.
Our group has been bioprospecting many Brazilian plants looking for potential new ‘hits’ to combat leish-
maniasis. We found that Baccharis platypoda was one of the Asteraceae species that displayed leishman-
icidal activity. We now describe the isolation of the new clerodane diterpene (1), named platypodiol after
its ethanolic leaf extract. Its structure was determined by detailed NMR and ESI-TOF/MS/MS experiments.
Considering the few publications about this species, this result has increased the phytochemical knowl-
edge about B. platypoda.
 2014 Elsevier Ltd. All rights reserved.Introduction
The plant family Asteraceae is comprised of more than 25,000
species found in tropical regions. This family is also known for
the great number of species that are used as medicinal plants.1 Bac-
charis is an important genus of the Asteraceae family, which com-
prised of about 500 American species, including 120 species from
Brazil.1,2 The infusions or decoctions of the aerial parts of some
of these plants are traditionally used as anti-inﬂammatory, diure-
tic, and digestive remedies.1
Flavonoids and diterpenes are the most frequent classes of nat-
ural products reported in Baccharis and they have been used as
chemotaxonomic markers.3 Among diterpenes, clerodane is the
major type found, occurring in more than 40 species of Baccharis,
including Baccharis artemisioides, Baccharis gaudichaudiana, Bac-
charis salicifolia, and Baccharis trimera.1
Plant extracts or plant-derived compounds are undoubtedly
valuable as a source of new medicinal agents.4 Due to the limited
number of drugs in leishmaniasis chemotherapy5,6, bioprospecting
programs aimed at ﬁnding new active compounds to develop
drugs for this illness are urgent. Detection of leishmanicidal activ-
ity from the crude ethanolic extract of Baccharis platypoda leaves,
as well as its non cytotoxicity to host cells was carried out by
our group previously. This result together with the few publica-tions about this species made us decide to select it for phytochem-
ical investigation.
Results/discussion
The leaves of B. platypodaweremaceratedwith ethanol and, after
ﬁltration, the solventwas removed under vacuum to yield the crude
extract. High-speed counter-current chromatography (HSCCC) was
used to fractionate the extract, resulting in 241 fractions that were
analyzed over TLC and grouped according to their chromatographic
proﬁle. This process resulted in 21 groups (G1–G21) which were
evaluated in the bioassay using human cell line THP-1 infectedwith
Leishmania amazonensis. Group 8 killed 100% of the parasites at
50 lg/mL and was fractionated (10 mg) by reversed-phase HPLC to
afford 6 mg of a white amorphous powder (1).
Compound 1 displayed optical activi ty ([a]D22 20, c 0.5,
MeOH). The ESI-Q-ToF-MS/MS analysis in the negative ion mode
showed an anionized molecule [M+HCO2] at m/z 367.2490, 100%
intensity (calcd 367.2485; 100%) and provided information on its
isotopic distribution: 13C 368.2517; 23% (calcd 368.2518; 23%)
and 14C: 369.2540; 3.9% (calc 369.2552; 2%). In the positive ion
mode a cationized molecule [M+Na]+ was detected at m/z
345.2391, 100% (calcd 345.2406; 100%), and its isotopic distribu-
tion of 13C: 346.2423; 21% (calcd 346.2439; 22%) and 14C:
347.2457; 2.9 (calcd 347.2473; 2%), suggesting amolecular formula
C20H34O3 (MW 322.2508 g/mol). The degree of unsaturation (u) for
this molecular formula suggests that the sum of rings plus
double bonds is four. The loss of H2O at the cationized molecule
Figure 1. Structure of platypodiol (1).
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jected to CID (15 eV) and a pattern of two more losses of H2O (m/z
287.2367 and m/z 269.2262) was observed. These three losses of
H2O indicate the presence of three hydroxyl groups at themolecule.
13C NMR and DEPT spectra analysis conﬁrmed the presence of
20 carbons comprising: four methyls; seven methylenes (two of
which at d 57.6 (C-15) and d 61.4 (C-17), hydroxylated); ﬁve
methines (being two oleﬁnics, at d 120.9 (C-3) and d 124.8 (C-
14), and one at d 73.8(C-6) hydroxylated); and four quaternary car-
bons with two oleﬁnic moieties, at d 144.5 (C-4) and 136.4 (C-13).
When two double bonds were detected by NMR, we deduced that 1
has two rings since its u is four. Indeed, the 13C NMR shifts at d
120.9 and 144.5 are typical for endocyclic double bond of clero-
dane diterpenes, which are assigned to C-3 and C-4, respectively.
The presence of a C-19 methyl carbon resonance in the 15–
20 ppm range is typically observed for clerodanes that show a
trans-ring fusion.7 The above information was in accordance with
a clerodane-type diterpenoid skeleton.8,9
The 1H NMR spectrum showed resonances for four methyl sing-
lets at d 1.57 (H-16), 1.76 (H-18), 0.93 (H-19), and 0.66 (H-20), and
two oleﬁnic signals at d 5.10 (H-3) and 5.24 (H-14). In COSY con-
tour map the methylene protons of the secondary alcohol (H-15)
occurred as a doublet at d 3.91 coupled to an oleﬁnic proton at d
5.24 (H-14). This, and the shielding of the related methyl resonance
at d 1.57 (H-16), are all compatible with a –C(Me)@CH–CH2OH sys-
tem as the terminal portion of the C-9 side-chain.10–12 COSY and
HMBC correlations observed in contour map are listed in Table 1.
The chemical shifts and coupling constants for H-15 and H-16
are in concordance with the values of related compounds isolated
from Baccharis species,10,13 furthermore the chemical shift of H-16
(d 1.57, s) indicated that the double bond between C-13 and C-14
was E conﬁgured (see Fig. 1).12
The relative stereochemistry of 1 was deduced from the NOESY
spectrum. The correlations observed for H-10/H-1 and H-10/H-8
were consistent with two six-membered rings fused with trans-
orientation and existed in twist-chair and chair conformation ofTable 1
1H and 13C NMR spectral data of compound 1 in DMSO-d6 (500 MHz for 1H NMR and
125 MHz for 13C NMR, d in ppm, J in Hz)
Pos. d C, type d H HMBC COSY
1 16.9, CH2 A: 1.44 (m, 1H) H-2B
B: 1,49 (m, 1H) H-2A
2 26.2, CH2 B: 1.92 (m, 1H)
A: 1.97 (m, 1H) H-3
3 120.9, CH 5.10 (br s, 1H) H-18 H-2,
H-18
4 144.5, C H-18, H-19
5 43.3, C H-18, H-19
6 73.8, CH 3.27 (m, 1H) H-19 H-7A
7 36.3, CH2 A: 1.34 (m, 1H) H-20 H-6
B: 1.43 (m, 1H)
8 42.1, CH 1.52 (m, 1H) H-20
9 37.1, C H-10,
10 45.3, CH 1.24 (br s, 1H) H-19, H-20 H-1A
11 32.4, CH2 A: 1.28 (d, J = 12.5, 1H) H-12A
B: 1.85 (m, 1H)
12 32.0, CH2 B: 1.67 (td, J = 12.5 and 5.0, 1H) H-16
A: 1.89 (m, 1H) H-11A
13 136.4, C H15, H-16
14 124.8, CH 5.24 (dd, J = 6.5, 1H) H-15, H-16 H-15
15 57.6, CH2 3.91 (d, J = 6.5, 2H) H-14
16 16.2, CH3 1.57 (s, 3H) H-14
17 61.4, CH2 A: 3.03 (dd, J = 9.8 and 9,5, 1H) H-8
B: 3.57 (dd, J = 9.8 and 3.5, 1H) H-8,
H-17B
18 22.5, CH3 1.76 (br s, 3H) H-3
19 15.2, CH3 0.93 (s, 3H) H-10
20 18.7, CH3 0.66 (s, 3H)
Figure 2. NOESY correlations of compound 1.clerodane-type diterpenes as reported in the literature.8 NOESY
correlations, as shown in Figure 2, were used to elucidate stereo-
chemistry. All of these results showed that compound 1 is the
new clerodane diterpene (1R,3R,4R,8aR)-3-(hydroxymethyl)-4-
[(3E)-5-hydroxy-3-methylpent-3-en-1-yl]-4,8,8a-trimethyl-1,2,3,
4,4a,5,6,8a-octahydronaphthalen-1-ol, named platypodiol. This
compound differs from similar clerodane diterpenes as it carries
three hydroxyl groups at C-6, C-15, and C-17. As this diterpene
showed only weak leishmanicidal activity the search for the bioac-
tive compound from the ethanolic extract is still in progress.
Conclusions
Clerodane-type diterpenes are ubiquitous in the Baccharis
genus. The results of the present study revealed a new member
of this class with a different hydroxylation pattern, contributing
to the phytochemical knowledge about B. platypoda. The search
for novel and more active compounds from this plant species is
in progress.
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